These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Eomes-Dependent Loss of the Co-activating Receptor CD226 Restrains CD8 Weulersse M; Asrir A; Pichler AC; Lemaitre L; Braun M; Carrié N; Joubert MV; Le Moine M; Do Souto L; Gaud G; Das I; Brauns E; Scarlata CM; Morandi E; Sundarrajan A; Cuisinier M; Buisson L; Maheo S; Kassem S; Agesta A; Pérès M; Verhoeyen E; Martinez A; Mazieres J; Dupré L; Gossye T; Pancaldi V; Guillerey C; Ayyoub M; Dejean AS; Saoudi A; Goriely S; Avet-Loiseau H; Bald T; Smyth MJ; Martinet L Immunity; 2020 Oct; 53(4):824-839.e10. PubMed ID: 33053331 [TBL] [Abstract][Full Text] [Related]
5. Exhausted CD8+T Cells in the Tumor Immune Microenvironment: New Pathways to Therapy. Jiang W; He Y; He W; Wu G; Zhou X; Sheng Q; Zhong W; Lu Y; Ding Y; Lu Q; Ye F; Hua H Front Immunol; 2020; 11():622509. PubMed ID: 33633741 [TBL] [Abstract][Full Text] [Related]
6. Differential requirements of CD4(+) T-cell signals for effector cytotoxic T-lymphocyte (CTL) priming and functional memory CTL development at higher CD8(+) T-cell precursor frequency. Umeshappa CS; Nanjundappa RH; Xie Y; Freywald A; Xu Q; Xiang J Immunology; 2013 Apr; 138(4):298-306. PubMed ID: 23113741 [TBL] [Abstract][Full Text] [Related]
7. The Emerging Role of CD8 Corgnac S; Boutet M; Kfoury M; Naltet C; Mami-Chouaib F Front Immunol; 2018; 9():1904. PubMed ID: 30158938 [TBL] [Abstract][Full Text] [Related]
8. Antigen-nonspecific activation of CD8+ T lymphocytes by cytokines: relevance to immunity, autoimmunity, and cancer. Ramanathan S; Gagnon J; Ilangumaran S Arch Immunol Ther Exp (Warsz); 2008; 56(5):311-23. PubMed ID: 18836862 [TBL] [Abstract][Full Text] [Related]
10. Human effector T cells derived from central memory cells rather than CD8(+)T cells modified by tumor-specific TCR gene transfer possess superior traits for adoptive immunotherapy. Wu F; Zhang W; Shao H; Bo H; Shen H; Li J; Liu Y; Wang T; Ma W; Huang S Cancer Lett; 2013 Oct; 339(2):195-207. PubMed ID: 23791878 [TBL] [Abstract][Full Text] [Related]
11. Adenosine mediates functional and metabolic suppression of peripheral and tumor-infiltrating CD8 Mastelic-Gavillet B; Navarro Rodrigo B; Décombaz L; Wang H; Ercolano G; Ahmed R; Lozano LE; Ianaro A; Derré L; Valerio M; Tawadros T; Jichlinski P; Nguyen-Ngoc T; Speiser DE; Verdeil G; Gestermann N; Dormond O; Kandalaft L; Coukos G; Jandus C; Ménétrier-Caux C; Caux C; Ho PC; Romero P; Harari A; Vigano S J Immunother Cancer; 2019 Oct; 7(1):257. PubMed ID: 31601268 [TBL] [Abstract][Full Text] [Related]
12. Microenvironment-Dependent Gradient of CTL Exhaustion in the AE17sOVA Murine Mesothelioma Tumor Model. Hope JL; Spantidea PI; Kiernan CH; Stairiker CJ; Rijsbergen LC; van Meurs M; Brouwers-Haspels I; Mueller YM; Nelson DJ; Bradley LM; Aerts JGJV; Katsikis PD Front Immunol; 2019; 10():3074. PubMed ID: 31998326 [TBL] [Abstract][Full Text] [Related]
13. The Antitumor Effects of Vaccine-Activated CD8 Wu S; Zhu W; Peng Y; Wang L; Hong Y; Huang L; Dong D; Xie J; Merchen T; Kruse E; Guo ZS; Bartlett D; Fu N; He Y Cancer Immunol Res; 2017 Oct; 5(10):908-919. PubMed ID: 28851693 [TBL] [Abstract][Full Text] [Related]
14. An Essential Role of the Avidity of T-Cell Receptor in Differentiation of Self-Antigen-reactive CD8+ T Cells. Kondo K; Fujiki F; Nakajima H; Yatsukawa E; Morimoto S; Tatsumi N; Nishida S; Nakata J; Oka Y; Tsuboi A; Hosen N; Oji Y; Sugiyama H J Immunother; 2016 Apr; 39(3):127-39. PubMed ID: 26938946 [TBL] [Abstract][Full Text] [Related]
15. CD8 Zhang B; Liu J; Mo Y; Zhang K; Huang B; Shang D Front Immunol; 2024; 15():1476904. PubMed ID: 39372416 [TBL] [Abstract][Full Text] [Related]
16. Chronic TCR-MHC (self)-interactions limit the functional potential of TCR affinity-increased CD8 T lymphocytes. Duong MN; Erdes E; Hebeisen M; Rufer N J Immunother Cancer; 2019 Nov; 7(1):284. PubMed ID: 31690351 [TBL] [Abstract][Full Text] [Related]
17. Potentiating CD8 Yuan J; Cai T; Zheng X; Ren Y; Qi J; Lu X; Chen H; Lin H; Chen Z; Liu M; He S; Chen Q; Feng S; Wu Y; Zhang Z; Ding Y; Yang W Protein Cell; 2021 Apr; 12(4):240-260. PubMed ID: 33606190 [TBL] [Abstract][Full Text] [Related]
18. The duration of TCR/pMHC interactions regulates CTL effector function and tumor-killing capacity. Riquelme E; Carreño LJ; González PA; Kalergis AM Eur J Immunol; 2009 Aug; 39(8):2259-69. PubMed ID: 19637198 [TBL] [Abstract][Full Text] [Related]
19. Cytotoxic CD8 Iwahori K Adv Exp Med Biol; 2020; 1224():53-62. PubMed ID: 32036604 [TBL] [Abstract][Full Text] [Related]
20. Differentiation and Regulation of T Basu A; Ramamoorthi G; Albert G; Gallen C; Beyer A; Snyder C; Koski G; Disis ML; Czerniecki BJ; Kodumudi K Front Immunol; 2021; 12():669474. PubMed ID: 34012451 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]